Search clinical trials for: apricitabine

Total 8 results

Avexa

Completed

A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects

HIV Infections

United States
Avexa

Withdrawn

A Long Term Safety Study of Apricitabine in HIV-infected Patients

HIV Infections
Avexa

Completed

Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together

HIV Infection

United States
Avexa

Completed

A Long Term, Safety Study of Apricitabine in HIV-infected Subjects

HIV Infection

Australia
Hoffmann-La Roche

Completed

A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C

Hepatitis C, Chronic

France, United States, Canada, Germany, Spain, Italy, Puerto Rico
Avexa

Terminated

Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection

HIV Infections

Canada, United States, Australia, United Kingdom, Thailand, Germany, Italy, Israel, Belgium, Puerto Rico, Peru
Hoffmann-La Roche

Completed

A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C

Hepatitis C

United States, United Kingdom, France, Canada, Spain, Italy, Germany
Avexa

Completed

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

HIV Infections

Australia

3

Subscribe